Aresko Progressive submits revised disclosure

24 Mar 2017 Evaluate

The Exchange has received the revised disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aresko Progressive.

The above information is a part of company’s filings submitted to BSE.

Jagsonpal Pharma Share Price

673.50 -20.15 (-2.90%)
27-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1749.50
Dr. Reddys Lab 1200.50
Cipla 1491.55
Lupin 2006.30
Zydus Lifesciences 950.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.